Epoetin Alfa Improves Anemia and Anemia-Related, Patient-Reported Outcomes in Patients with Breast Cancer Receiving Myelotoxic Chemotherapy: Results of a European, Multicenter, Randomized, Controlled Trial

PURPOSE. To evaluate the effects of epoetin alfa on patient-reported outcomes (PROs) in patients with breast cancer receiving myelotoxic chemotherapy. MATERIALS AND METHODS. Women with hemoglobin concentrations ≤12.0 g/dl and an Eastern Cooperative Oncology Group performance status (ECOG PS) score o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pronzato, Paolo, Cortesi, Enrico, van der Rijt, Carin C., Bols, Alain, Moreno-Nogueira, José A., de Oliveira, Carlos Freire, Barrett-Lee, Peter, Ostler, Peter J., Rosso, Ricardo
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2010
Assuntos:
Academia–Pharma Intersect
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228044/
https://ncbi.nlm.nih.gov/pubmed/20798194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2009-0279
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados